Alzheimer's disease: soluble oligomeric Abeta(1-40) peptide in membrane mimic environment from solution NMR and circular dichroism studies

scientific article published in December 2004

Alzheimer's disease: soluble oligomeric Abeta(1-40) peptide in membrane mimic environment from solution NMR and circular dichroism studies is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1043423000
P356DOI10.1007/S11064-004-7035-1
P698PubMed publication ID15672549
P5875ResearchGate publication ID226907546

P2093author name stringPravat K Mandal
Jay W Pettegrew
P2860cites workElevated phosphocholine and phosphatidylcholine following rat entorhinal cortex lesionsQ48710372
Water-soluble Abeta (N-40, N-42) oligomers in normal and Alzheimer disease brainsQ49112901
A common sense approach to peak picking in two-, three-, and four-dimensional spectra using automatic computer analysis of contour diagrams. 1991.Q51479050
Changes in brain energy and phospholipid metabolism during development and aging in the Fischer 344 rat.Q52241507
Molecular membrane interactions of a phospholipid metabolite. Implications for Alzheimer's disease pathophysiology.Q53211456
Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability.Q53248798
Two types of Alzheimer's beta-amyloid (1-40) peptide membrane interactions: aggregation preventing transmembrane anchoring versus accelerated surface fibril formation.Q53259393
31P Nuclear Magnetic Resonance Study of the Brain in Alzheimerʼs DiseaseQ53304910
Physicochemical studies of the protein-lipid interactions in melittin-containing micellesQ66991412
Interaction of Alzheimer beta-amyloid peptide(1-40) with lipid membranesQ73940275
Attenuated T2 relaxation by mutual cancellation of dipole-dipole coupling and chemical shift anisotropy indicates an avenue to NMR structures of very large biological macromolecules in solutionQ24649924
The Xplor-NIH NMR molecular structure determination packageQ27860805
NMRPipe: a multidimensional spectral processing system based on UNIX pipesQ27860859
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesisQ29547501
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxinsQ29547593
Amyloid beta-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate.Q30327817
Molecular insights into Alzheimer's diseaseQ31058930
Amyloid fibrillogenesis: themes and variationsQ33840755
A broken alpha -helix in folded alpha -SynucleinQ34177224
31P nuclear magnetic resonance (NMR) spectroscopy of brain in aging and Alzheimer's disease.Q36447528
Beta-amyloid 25 to 35 is intercalated in anionic and zwitterionic lipid membranes to different extentsQ40217129
Correlation of phosphorus-31 magnetic resonance spectroscopy and morphologic findings in Alzheimer's diseaseQ41399691
Brain membrane phospholipid alterations in Alzheimer's diseaseQ43743686
Alzheimer's disease: NMR studies of asialo (GM1) and trisialo (GT1b) ganglioside interactions with Abeta(1-40) peptide in a membrane mimic environmentQ44787563
31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: preliminary observationsQ45298431
Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons.Q48093908
Distribution and fluidizing action of soluble and aggregated amyloid beta-peptide in rat synaptic plasma membranesQ48183391
Neurodegenerative disease: amyloid pores from pathogenic mutationsQ48544171
P433issue12
P921main subjectAlzheimer's diseaseQ11081
P304page(s)2267-2272
P577publication date2004-12-01
P1433published inNeurochemical ResearchQ15716728
P1476titleAlzheimer's disease: soluble oligomeric Abeta(1-40) peptide in membrane mimic environment from solution NMR and circular dichroism studies
P478volume29

Reverse relations

cites work (P2860)
Q38093077Advances in electrochemical detection for study of neurodegenerative disorders
Q48685462Alzheimer's disease: halothane induces Abeta peptide to oligomeric form--solution NMR studies
Q30152727Aβ42 assembles into specific β-barrel pore-forming oligomers in membrane-mimicking environments
Q41240079Binding of the three-repeat domain of tau to phospholipid membranes induces an aggregated-like state of the protein.
Q52661940Cause and consequence of Aβ - Lipid interactions in Alzheimer disease pathogenesis.
Q45585277DHPC Strongly Affects the Structure and Oligomerization Propensity of Alzheimer's Aβ(1–40) Peptide
Q41607092Fatty Acid Concentration and Phase Transitions Modulate Aβ Aggregation Pathways.
Q37725710Fluorescence spectroscopy of protein oligomerization in membranes.
Q39422055Impact of a discordant helix on β-amyloid structure, aggregation ability and toxicity.
Q42726604Impacts of membrane biophysics in Alzheimer's disease: from amyloid precursor protein processing to aβ Peptide-induced membrane changes
Q48126441Insight into the modulation of Shaw2 Kv channels by general anesthetics: structural and functional studies of S4-S5 linker and S6 C-terminal peptides in micelles by NMR.
Q48431408Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease
Q30819640Measuring translational diffusion coefficients of peptides and proteins by PFG-NMR using band-selective RF pulses
Q30155996Models of membrane‐bound Alzheimer's Abeta peptide assemblies
Q40183106Molecular understanding of Abeta peptide interaction with isoflurane, propofol, and thiopental: NMR spectroscopic study
Q39322110Self-assembling peptide and protein amyloids: from structure to tailored function in nanotechnology.
Q59021206Spectroscopic Investigations of Pentobarbital Interaction with Transthyretin
Q46902534Structural analysis of the pyroglutamate-modified isoform of the Alzheimer's disease-related amyloid-β using NMR spectroscopy
Q27655538Three-Dimensional Structure and Orientation of Rat Islet Amyloid Polypeptide Protein in a Membrane Environment by Solution NMR Spectroscopy

Search more.